Since falling to an $8.25 low in April, American Airlines Group (NASDAQ:AAL) is holding the $10.00 level. Markets have a wait and see approach on AAL stock because its business recovery depends on passenger traffic rebounding.Source: GagliardiPhotography / Shutterstock.com Realistically, investors should expect a sustained uptrend in air flight demand in the coming weeks. Businesses are opening across the United States, and as companies hire back staff and at-home workers travel, expect business travel levels increasing.In the last week (week of May 18 - 22, 2020), the Transportation Security Administration reported that total travel throughput increased by around 33%. This is also more than triple from the April lows.InvestorPlace - Stock Market News, Stock Advice & Trading TipsDate Total Traveler Throughput Total Traveler Throughput (1 Year Ago - Same Weekday) 5/22/2020 348,673 2,792,670 5/21/2020 318,449 2,673,635 5/20/2020 230,367 2,472,123 5/19/2020 190,477 2,312,727 5/18/2020 244,176 2,615,691 Data courtesy of TSAThe airline industry...
(Bloomberg) -- Biotechnology stocks saw broad swings Friday morning as investors worked their way through a deluge of data from cancer drug developers presenting at the American Society of Clinical Oncology’s virtual annual meeting.Wall Street was quick to crown small-caps Adaptimmune Therapeutics Plc and Trillium Therapeutics Inc. as well as heavyweight AstraZeneca Plc among the early winners with shares rallying on the back of their respective updates. On the flip side, uninspiring results from Arvinas Inc.’s prostate cancer study and Aveo Pharmaceuticals Inc.’s kidney cancer trial drove investors to punish shares.Here’s a breakdown of some of ASCO’s biggest winners and losers:Adaptimmune TherapeuticsThe small developer of cell therapies more than doubled in Friday’s session after announcing updated early-stage results from a handful of trials in a range of cancer types. The company said its treatments drove responses in esophagogastric junction, lung, and head and neck cancer patients. Adaptimmune plans to start a...
Aircraft makers are circling Brazil's Embraer weeks after Boeing ditched plans for a historic commercial aviation tie-up, people familiar with the matter said. Boeing axed plans to buy 80% of Embraer's commercial unit in April, ending a planned move into regional jets that mirrored rival Airbus' purchase in 2018 of a competing model developed by Canada's Bombardier. China's state-owned COMAC planemaker has voiced informal interest in co-operation with the world's third-largest jetmaker, two of the people said....
President Donald Trump is expected to make an announcement regarding relations between the U.S. and China on Friday. Arthur Dong, Georgetown University Professor, joins Yahoo Finance's Alexis Christoforous and Brian Sozzi to discuss that more....